NovoCure Ltd
Develops a non-invasive electric field therapy to disrupt and treat aggressive solid tumor cancers.
NVCR | US
Overview
Corporate Details
- ISIN(s):
- JE00BYSS4X48
- LEI:
- Country:
- United States of America
- Address:
- NO. 4 THE FORUM, 0 ST. HELIER
- Website:
- https://www.novocure.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
NovoCure is a global oncology company focused on developing and commercializing its novel cancer therapy, Tumor Treating Fields (TTFields). This therapy utilizes low-intensity electric fields, delivered via a non-invasive medical device, to disrupt the division of solid tumor cancer cells. The company's primary mission is to extend survival in some of the most aggressive forms of cancer. NovoCure maintains an active clinical pipeline with multiple late-stage trials investigating the efficacy of TTFields across various cancer types, including pancreatic, lung, and brain tumors. Founded in 2000, the company is dedicated to advancing this innovative treatment modality through extensive research and clinical development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NovoCure Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NovoCure Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NovoCure Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
